IMF Chairman Dr. Brian G.M. Durie weighed in on the high cost of cancer drugs after the recent article in Mayo Clinic Proceedings. He discusses what needs to be done within the healthcare system to better serve the patients.


Image of Dr. Brian G.M. DurieDr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.

Previous Post
Bringing Next Generation Flow (NGF) Cytometry to Japan
Next Post
What Is the Solution for the Rising Cost of Cancer Drugs?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.